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Abstract

MAST CELLS IN KAINATE RECEPTOR KNOCKOUT MICE
Andrea J. Elkovich
Bachelors of Science– Virginia Commonwealth of University, 2011
A thesis submitted in partial fulfillment of the requirements for the degree of Master of
Science at Virginia Commonwealth University

Virginia Commonwealth University, 2015
Director: Daniel Conrad, Ph.D. Professor
VCU Department of Microbiology & Immunology
Kainate receptor knockout mice have unique differences within their immune
system. They exhibit an attenuated TH2 branch, while maintaining a robust TH1 response.
Specifically, blocking the formation of functional kainate receptors affects mast cells and
their related pathologies. While they seem to develop and activate normally in vivo and
in vitro, KAR KO mast cells release more inflammatory mediators upon degranulation.
These mice experience severe anaphylactic shock due to two compounding
abnormalities. First, KAR KO mast cells release significantly more histamine in vivo
upon IgE-mediated activation. Second, the animals over-respond to exogenous histamine
with drastic temperature drops compared to WT.
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-Chapter 1: IntroductionAllergies and the Immune System
Atopic disease, or Type I Hypersensitivity, is an IgE-mediated immune response
against innocuous environmental antigens1. Due to a combination of genetic and
environmental factors, certain individuals are prone to producing excessive IgE antibodies
against common allergens such as pollen or dander1,2. These antibodies then become
localized in the tissue by binding their high affinity receptor, FcεRI, on resident mast cells.
Upon re-exposure to multivalent antigen, the IgE becomes cross-linked and activates the mast
cells to release pro-inflammatory mediators, leading to the well-known symptoms of IgEmediated allergic disease
Mast cell activation is biphasic and therefore gives rise to different clinical symptoms
classified as either from the early or late response2–4. Seconds after IgE is cross-linked, the
activating signal causes the mast cell to degranulate. This immediate release of pre-formed
mediators causes the characteristic symptoms of allergic reaction shown below in Figure 1-1.

Vasoactive amines
(histamine, seratonin),
proteoglycans (heparin,),
proteases (tryptase,
chymase)

Increased vascular
permeability, smooth muscle
contraction, mucus
production/secretion

Airway obstruction/wheezing,
congestion, edema,
temperature/blood pressure drop

De novo synthesis of
eicosanoids, chemotractants,
cytokines

Immune cell recruitment/
activation, second round of
smooth muscle contraction,
vasodilation / permeability

Chronic inflammation, tissue
remodeling, airway
hyperreactivity

!
Figure 1-1. Mast cell mediators cause allergic symptoms.
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Following activation, de novo synthesis slowly produces and releases molecules that
will facilitate the late phase. Originally derived from membrane phospholipids, arachidonic
acid is converted into prostaglandins, thromboxanes, and leukotrienes. This group of lipid
mediators is collectively known as eicosanoids (Figure 1-2).

Figure 1-2. De novo synthesis of eicosanoids.
PLA2 converts membrane phospholipids into arachidonic acid and lyso-PC.
Arachidonic acid is metabolized into leukotrienes, prostaglandins, and
thromboxanes. Lyso-PC is the precursor for platelet activating factor.

In combination with other delayed-release cytokines, the late phase is marked by the
influx and activation of leukocytes four to six hours later. Eosinophilia and the general
inflammatory environment facilitates a second round of smooth muscle contraction and
prolonged edema. In anaphylaxis, this presents with abdominal pain and shortness of breath5.
In the asthma, this can contributes to airway remodeling and the development of airway
hyperreactivity (AHR), especially if the antigen persists. Eventually this state of chronic
inflammation leaves the body susceptible to flare-ups triggered by unrelated environmental
irritants such as smoke4.

!
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Although a large portion of society in developed countries suffers from allergies
today, this TH2 type of immunity originally evolved from humanity’s battle against
multicellular parasites. Mast cells stand guard at vulnerable entry points of invasion,
specifically clustered around vessels in mucosal and epithelial tissues6. A common defense
against intestinal infections, such as Heligmosomoides polygyrus, is the STAT6-mediated
“weep and sweep.” This process involves increased luminal secretions—weep, and
contractility—sweep, intended to expel the worms6. Recruited immune cells can accumulate
to form granulomas around the physical invaders or release mediators to directly damage
them6. Such protective effects, however, become harmful during inappropriate activation by
allergens. The acute inflammation triggered by mast cells and eosinophils is meant to resolve
upon parasite clearance. Ubiquitous environmental allergens, however, cause persistent
inflammation with harmful effects; in essence, the body’s protective response becomes
destructive, causing irreversible tissue damage in chronic diseases2.
Systemic anaphylaxis is the most severe example of an inappropriate immune
response. The reaction progresses rapidly, causing extensive vascular fluid loss that results in
respiratory or cardiovascular collapse and even death7. Mast cell degranulation is again
responsible for the sudden onset as well as the delayed wave of symptoms. Because this
condition is systemic, the vasoactive mediators cause a devastating drop in blood pressure
and temperature that can be used to gauge the severity of the reaction.

Balance Between TH1 and TH2
The paradigm between TH1 and TH2 immunity stems from a 1986 publication that
described the cytokine patterns of two divergent helper T cell populations8. Mosmann et al.!

!
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characterized Type I T cells by IL-2 and IFN-γ production and Type II T cells by IL-4
(reported as MCGF-2) and T Cell Growth Factor 2 (TCFG-2). The Type II clone was further
characterized by its ability to elicit polyclonal IgE and IgG1 production by lipopolysaccharide
(LPS)-stimulated B cells8. This group also coined the terms TH1 and TH2 that we use today.
IFN-γ and IL-2 are now recognized as classic TH1 cytokines that direct immune
responses against viruses and other intracellular pathogens. TH2-derived IL-4 and IL-5
command the humoral response against multicellular parasites and extracellular pathogens. It
is important to mention that we also recognize a plethora of other T cell subtypes (TH0, TH17,
Tregs); what binds TH1/TH2 together is their ability to up-regulate their own activities, while
repressing their counterpart9. Figure 1-3 demonstrates how TH2 cells secrete IL-10, which
blocks the production of IFN-γ, and IL-4 further skews toward a TH2 environment. TH1produced IFN-γ, on the other hand, blocks TH2 cells from proliferating, while secreting selfenhancing IL-2.

Figure 1-3. Balance between TH1 and TH2 skewing of the immune system.
Both cell types produce cytokines to enhance themselves while also blocking
the other.
This balance of power is often used as a simplified dogma or foundation to study the
complex interactions between immune components9. According to the paradigm, we assume
there is a resting homeostasis between the two branches. Upon antigen challenge, naïve TH0
cells become polarized toward the branch which is appropriate for clearance. When all goes

!
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well and the cell is committed, the irrelevant branch is weakened so that the appropriate
branch can mount a robust response.

TH2 Infection Model
Hailing from the phylum Nematoda, Nippostrongylus brasiliensis (Nb) is a parasite of
rodents. Similar to the human hookworm, Nb establishes infection within the host’s intestines
for the purpose of reproducing; its life cycle shown in Figure 1-4. Secreted cytokines,
including IL-4, 5, 9, and 13, direct the protective response toward IgE production,
eosinophilia, mucosal mast cell expansion, and mucus production6. Together, this previously
mentioned “weep-and-sweep” defense succeeds in expelling the worms within two weeks.
Although localized within the mucosa, the infection triggers a systemic TH2 immune
response, making it an ideal model to study in vivo13.

Figure 1-4. Nippostrongylus brasiliensis life cycle1.
Stage-3 larvae enter their rodent host through the skin of the footpad. Following the
bloodstream, the worms reach the lungs where they mature to stage-4 larvae. The worms are
coughed up and subsequently swallowed. Within the small intestines the worms mature to
stage-5 and reproduce. Eggs become incorporated into the feces.
1
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TH1 Model
Lydia Rabinowitsch was the first to report the formation of tubercles at the injection
site of fatty substances. She found that Mycobacterium butyricum, only when incorporated
into butter, caused a local granuloma reaction14. Intrigued by these results, Jules Freund
began to experiment on the use of lanolin-like substances and paraffin oil as adjuvants.
In 1944, Freund published a comprehensive study verifying the benefit of adjuvants in
enhancing and sustaining antibody and anti-toxin production. He described the microscopic
phenomenon of water-in-oil emulsion, his original drawing shown in Figure 1-5, and noted
that the incorporation of heat killed bacteria created an additional synergistic effect15. Soon to
follow were reports that paraffin oil boosted immediate and long-term virus immunity in
experimental animals16,17 and human influenza vaccines18.
Freund’s research resulted in the emulsion adjuvant that is commonly used today in
animals. Freund’s Incomplete Adjuvant (IFA) is a water-in-oil (W/O) emulsion of heavy
paraffin/mineral oil with an antigen-containing water phase19. Because these two substances
are immiscible, a surfactant must be added in order to stabilize the interface.

Figure 1-5. Water-in-oil emulsion.
As drawn by Jules Freund in his 1944
publication15.

Mannide monooleates, such as Aralacel A, are lipophilic emulsifying agents that allow
tiny aqueous droplets to exist within an oil phase. This final mixture allows for a slow and
even release of the suspended antigen, resulting in a prolonged immune response.!

!
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Specifically, IFA stimulates the innate immunity to eventually skew toward TH1, giving rise
to the increased resistance to bacterial infection reported by Castro in 199320.
Adding heat-killed Mycobacterium tuberculosis gives Freund’s Complete Adjuvant
(CFA). CFA is a much more potent adjuvant because the Pathogen-Associated Molecular
Patterns (PAMP) on the bacteria additive activates Toll-Like Receptors (TLR) on antigenpresenting cells (APC). The resulting danger signals lead to a robust TH1 response21.
!
!

Mast Cell Receptor FcεRI
FcεRI is member of the family of Fc receptors (FcR), which in turn are members of
the immunoglobulin supergene family22,23. The name and designated Greek letter refer to the
fact that these receptors bind the fragment, crystallizable (Fc) portion of different antibody
isotypes1; for example, FcεRI binds the Fc region of IgE molecules. FcR’s are expressed
mainly in the myeloid lineage including mast cells, macrophages, and neutrophils, but also on
lymphoid B cells and occasionally on non-immune cells like endothelial cells22,23.
Structurally, FcεRI is a multi-chain complex with the ability to bind ligand and
transduce signals. The alpha-chain, shown in blue in Figure 1-6 is a 45kDa protein that
directly interacts with circulating IgE1. The 33kDa tetra-spanning beta-chain, shown in red,
serves a widely accepted role of signal amplification24,25. The final component of FcεRI is the
9kDa homodimer gamma chain pair shown in green. The gamma chains are crucial for
initiating signal transduction through its ITAMs (Immunoreceptor Tyrosine-based Activation
Motifs). Known as a common gamma chain, it is found in other Fc receptors, including
FcαRI, FcγRI, III, and IV1.!

!
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Figure 1-6. Structure of murine FcεRI2.
Alpha-chain (blue) binds IgE, beta-chain (red) amplifies the signal, gamma-chains (green)
initiates signaling. Beta- and gamma-chains contain ITAMs to propagate signaling cascade.

Signaling Through FcεRI
In 1911, pathologist Peyton Rous was experimenting with cancer transmission. In
addition to transplanting the malignant mass, he was surprised to find he could also establish
tumor in a new host by injecting the cell-free extract from a donor tumor26. He hypothesized
that a “minute parasitic organism” was responsible for this transmission. This so-called Rous
Sarcoma Virus (RSV) became widely studied and eventually lead to the discovery of a single
gene that caused cellular transformation27. C-Src, named as an abbreviation of sarcoma, is a
proto-oncogene that encodes a family of vital signaling enzymes called Src family kinases.
Phosphorylation by Src regulates signaling activity by allowing communication between
surface receptors with intracellular machinery. Taking a broad look, Src kinases regulate
many basic cellular processes such as growth and differentiation27.
2

!

FcεRI adapted from external source
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In the case of mast cells, several Src kinases play key roles in proximal activation
signaling. Loosely associated with FcεRI, Lyn becomes activated upon receptor aggregation
and phosphorylates the tyrosine residues on the beta- and gamma-chain ITAMs24 shown in
Figure 1-6. This creates a high affinity-docking site for Syk, another early activated tyrosine
kinase, that will phosphorylate the adaptor molecule LAT (Figure 1-7 A)24,28. Linker for
Activation of T cells (LAT) serves as a scaffold for the formation of the macromolecular !
complex required for downstream signaling.

A

B

D
C

Figure 1-7. Mast cell activation through FcεRI.
A) Receptor aggregation activates Lyn to phosphorylate Syk, which in turn activates LAT.
B) Receptor aggregation also activates Fyn to phosphorylate PI3-K, which in turn
phosphorylates PIP2 to PIP3. Membrane PIP3 recruits PLCγ.
C) Upon activation by BTK, LAT directs PLCγ activity to hydrolyze PIP2 into DAG and IP3.
This splits the signaling down two separate paths. IP3 triggers calcium mobilization.
D) DAG recruits PKC to LAT, which activates a MAPKKK cascade resulting in cytokine and
arachidonic acid production.
!
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Also activated during aggregation is Fyn, the other Src kinase involved in mast cell
signaling. Fyn drives a complementary cascade that is separate from the one initiated by Lyn,
but both are required for degranulation29. Fyn activates Phosphoinositide 3-kinase (PI3-K)
indirectly through the membrane protein Gab224. PI3-K adds an additional phosphate group
to PIP2, producing PIP3.!
The main signaling enzyme Phospholipase C-gamma (PLC-γ) is recruited to
membrane PIP3 and activated by BTK. LAT directs PLC-γ activity by its four vital tyrosine
residues (Y132, 171, 191, 226). PLC-γ hydrolyzes Phosphatidylinositol (4, 5)-bisphosphate
(PIP2) into Inositol trisphosphate (IP3) and Diacylglycerol (DAG) (Figure 1-7 C). These two
molecules will continue down separate paths leading to calcium mobilization, and PKC
activation and degranulation, respectively25,28.
Membrane-bound DAG helps to localize and activate protein kinase C (PKC) to the
plasma membrane. Although not well understood, PKC somehow activates and regulates the
multi-tiered MAPK/ERK pathway (Figure 1-7 D). Mitogen-activated protein kinase (MAPK)
cascades are an important link between signaling molecules and the nucleus1. The final
enzyme of the series is able to phosphorylate and activate transcription factors, leading to new
gene expression; in the case of mast cells, these genes encode a variety of pro-inflammatory
mediators28. Additionally, Phospholipase A2 (PLA2) is activated by this relay, allowing
eicosanoid production (Figure 1-7 D).
IP3 induces a transient release of intracellular calcium stores from the endoplasmic
reticulum (ER)28,30 (Figure 1-8). Eventually this limited internal supply runs low, alerting
Stromal Interaction Molecule-2 (STIM-2) to communicates with its counterpart STIM-1 on
the plasma membrane31put. Together, these proteins initiate extracellular calcium influx!

!
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Figure 1-8. Capacitative calcium flux.
IP3 activates its receptor on the endoplasmic reticulum, opening a channel to release calcium
from the lumen. Once the intracellular stores are drained, STIM-2 senses the low [Ca2+] and
signals STIM-1 to activate SOC. Also known as CRAC, this channel allows calcium influx to
replenish intracellular stores. If ER-stored calcium is at a high enough concentration, STIM-2
remains inactive and SOC is closed to prevent ion flow.

through plasma membrane Store Operated Calcium (SOC) channels30. Also referred to as
Calcium Release Activated Channels (CRAC), these calcium-selective channels are
composed of four pore- forming subunits of the protein Orai31. Capacitative calcium entry
replenishes the supply, sustaining the calcium flux28,31. Calcium signaling within the mast cell
will contribute to new gene expression by activating transcription factors1 and secretion of
mediators through granule trafficking24.!
!
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Antibodies
Upon infection or immunization, activated TH cells can partake in cognate interactions
with naïve B cells. Three signals are required to stimulate further B cell activity: 1. CD40ligand, 2. MHC-II / TCR, 3. secreted cytokines to direct differentiation. Activated B cells
can then become plasma cells, which secrete special effector proteins that bind to foreign
particles. Known as antibodies, these proteins generally function within the adaptive immune
system to neutralize toxins and tag pathogens for destruction by phagocytic cells1.
The common protein structure, shown in Figure 1-9a, consists of two identical heavy
chains (orange) and two identical light chains (yellow). The heavy chains, weighing between
50-73kDa, exist in five classes: A/alpha (α), G/gamma (γ), D/delta (δ), E/epsilon (ε), and
M/mu (μ). These isotypes vary depending on four characteristics: number and location of
disulfide bonds, number and location of oligosaccharides, number of constant domains, and
the length of the hinge region. The light chains, on the other hand, only exist in two forms:
lambda (λ) and kappa (κ). Although there is no known functional difference between the
two, an antibody will only contain two lambda or two kappa light chains; an antibody never
contains one of each1.!

a

b

c

Figure 1-9. Antibody structure.
a. Heavy chain (orange), light chain (yellow)
b. Variable region (blue), constant region (green)
c. Fab (pink), Fc (purple)

!
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The functional region is confined to the c-terminus, known as the constant region,
shown in green in Figure 1-9b. Based on the heavy chain’s isotype, the constant region
determines with which cells the antibody can interact and what immune mechanisms it can
initiate. The n-terminal variable region, shown in blue, binds to a distinct antigen epitope that
was determined by the unique amino acid sequence of the B cell’s receptor (BCR). All
antibodies produced by this cell or its daughters will be specific for the same epitope. And
although each produces only a single clone, every B cell in the body recognizes a different
epitope, allowing the immune system to recognize a huge array of foreign antigens1.
Another useful way to discuss antibody structure is via the fragments produced by
proteolytic cleavage. Papain cleaves around the hinge disulfide bonds, liberating three
fragments: two Fab and one Fc. Shown in pink in Figure 1-9c, the two Fragments, antigenbinding (Fab) contain the variable regions. Fragment, crystallizable, shown in purple,
contains the constant region that will bind the appropriate Fc receptors for the isotype1.
As mentioned before, there are five different Ig isotypes, all which originate from a
single modular gene, shown schematically in Figure 1-10a. During isotype switching,
double-stranded breaks within the DNA allow deletions to be made. Upstream of each
constant region, there is a switch region that is acted upon by Activation-Induced Cytidine
Deaminase (AID). AID can only access these nucleotides, however, if the DNA strands are
separated1.
In the case of IgE, CD40-L and IL-4 activate STAT6 and NF-κB within the B cell.
These transcription factors initiate transcription of their target constant region, epsilon, in
order to open the DNA and separate the two strands. At this point, AID is able to come in and
convert cytosine residues into uracil via deamination (Figure 1-10a). Uracil DNA!

!
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Glycosylase (UNG) and Apyrimidinic Endonuclease-1 (APE-1), proteins involved in DNA
repair, will nick the single-stranded DNA at each of these uracils, triggering double-strand
break repair machinery. In the end, the two switch regions targeted by AID are joined (Figure
1-10b), while the intervening DNA is cut out (Figure 1-10c). When transcription is initiated
at the V region promoter, the epsilon constant region results and IgE is produced1.!

a

c
b

Figure 1-10 IgE isotype switching
AID deaminates random cytosine residues within the switch region to prompt single-strand
breaks (a). Upon circularization and excision (c), the epsilon constant region joins with the
upstream VDJ component for transcription (b).

Figure 1-11 shows the general structure of IgE. It is a heavily glycosylated, 200kDa
protein32. Each heavy chain is made up of four subunits or constant domains, one of which
takes the place of the hinge region1. Of all the isotypes, IgE is the most heavily regulated; in
normal circulation, only 10-400 ng/mL will be detected. IgE has a short half-life and!
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typically decays between 12 hours and two days; binding to an Fc receptor will stabilize the
antibody and extend its existence for several weeks32.!

Figure 1-11 IgE protein structure
A 200kDa, heavily glycosylated protein, containing
four constant domains with no hinge region.

Glutamate and Its Receptors
Upon discovery of glutamate as the primary excitatory neurotransmitter, research into
its receptors (GluR’s) began. Glutamate is recognized by a variety of receptors that are firstly
divided into an ionotropic or metabotropic class based on their overall structure and function.
In general, ionotropic receptors (iGluR) are ligand-gated ion channels that can both bind the
neurotransmitter and allow ion flux through its integral channel. Metabotropic receptors
(mGluR) do not have a built-in ion channel, so they must signal through a coupled G-protein
in order to trigger eventual ion movement33.
Excitotoxicity in the peripheral tissues was investigated in the mid 1990’s by Said, et
al. who showed that GluR over-activation could cause lung and airway damage in rats34. In
this case, the group observed high-permeability pulmonary edema directly related to dosedependent NMDA treatments. Since then, the group has shown evidence that supports a
relationship between iGluR activation and airway inflammation and hyper-reactivity35.

!
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Figure 1-12 Structure of glutamate

Here we focus on ionotropic glutamate receptors (iGluR), which can be further subdivided into N-methyl-D-Aspartate (NMDA), α-amino-3-hydroxy-5-methyl-4isoxazolepropionic acid (AMPA), and Kainate (KA). These subtypes are modular and
characterized by the heteromeric subunits that make it up, as well as their preferred ligand.
Within the brain, iGluR’s participate in fast excitatory synaptic transmission33.
Studies since the early 1990’s, however, have found the existence of peripheral GluR.
Circulating glutamate levels can vary between 30-100uM33, so their presence outside the CNS
is not so arbitrary. Many groups have studied the expression and function of peripheral
iGluRs on pancreatic islet cells36, T cells37, stomach38, taste receptor cells39, and many more
cell and tissue types. While the NMDA receptor is the focus of much of today’s iGluR
research, our group studies the often-ignored Kainate receptor (KAR).
This report investigates the phenotype of KAR KO mice, specifically any deficits in
atopic disease within the immune system.
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-Chapter 2: Materials and MethodsSection 1: Animals
-Mice
B6/129 colonies were maintained within a VCU Department of Animal Research (DAR)
vivarium. Animals of at least six weeks of age were used according to protocols approved by the
VCU Institutional Animal Care and Use Committee (IACUC).

-Mouse Euthanasia
All mice were sacrificed by an overdose inhalation of Isoflurane followed by cardiac
puncture or cervical dislocation.

Section 2: Bone Marrow Derived Mast Cells
-Mast Cell Media
All mast cells were cultured in complete RPMI 1640 media (Invitrogen Life
Technologies – Carlsbad, CA) containing 10% heat-inactivated FBS, 2mM L-Glutamine (cat#
SH30034 HyClone- Logan, UT), 1mM Sodium Pyruvate (cat# SH30239 HyClone- Logan, UT),
1mM HEPES (cat# SH30237 HyClone- Logan, UT), 100 units/mL Penicillin G, 100μg/mL
Streptomycin (Cat# SV30079 HyClone- Logan, UT), and supplemented with 5ng/mL
recombinant IL-3 and 10ng/mL SCF.

-BMMC Culture
Femurs and tibias were surgically removed from deceased mice. The ends of the bones
were sliced off to form an open tube. Bone marrow was isolated by centrifugation for five
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minutes at 1500 RPM. Red blood cells were removed from the pellet by adding 15mL ACK
Lysis Buffer. Cells were washed in 1X PBS then resuspended and maintained at 500,000
cells/mL in Mast Cell Media for at least three weeks of incubation before checking surface
expression of FcεRI and c-kit by flow cytometry.

Section 3: B Cell Culture and Analysis
-Glutamate-Free RPMI Media
The powder base was special ordered as a modification of RPMI (cat# 31800022 Life
Technologies- Carlsbad CA) with L-Glutamic Acid and L-Glutamine removed. Media was
prepared with the addition of 10% heat-inactivated FBS, 2mM L-Glutamine (cat# SH30034
HyClone- Logan, UT), 1mM Sodium Pyruvate (cat# SH30239 HyClone- Logan, UT), 1mM
HEPES (cat# SH30237 HyClone- Logan, UT), 100 units/mL Penicillin G, 100μg/mL
Streptomycin, 0.25μg/mL Amphotericin (Cat# SV30079 HyClone- Logan, UT), 50μM 2Mercaptoethanol. pH to 7.4

-In vitro Culture
B220+ B cells were isolated from splenocytes using CD45R magnetic bead selection
(Miltenyi Macs- Auburn, CA). Cells were plated at descending densities, starting at 20,000
cells/well in a final volume of 200μL glutamate-free RPMI. The cultures were stimulated with
1ng/mL IL-4 (Peprotech- Rocky Hill, NJ) and 1.25μg/mL anti-mouse CD40 (cat# 102902
BioLegend- San Diego, CA). After nine days of incubation, supernatants were harvested and
analyzed for IgE levels by ELISA.
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-IgE ELISA
Wells were coated with 5μg/mL B1E3, rat monoclonal anti-mouse IgE, for one hour at 37
degrees Celsius. Samples and standards were left overnight at four degrees Celsius. A
biotinylated R1E4, anti-mouse IgE antibody, was incubated for one hour at 37 degrees Celsius.
Streptavidin-AP was incubated for 45 minutes at 37 degrees Celsius. Following substrate
addition, plates were read at 405-650nm.

Section 4: Mast Cell Migration Assay
-Migration Media
RPMI 1640 media was supplemented with 100 units/mL Penicillin G and Streptomycin
(Cat# SV30079 HyClone- Logan, UT), 2mM L-glutamine (cat# SH30034 HyClone- Logan, UT),
1mM HEPES (cat# SH30237 HyClone- Logan, UT), and 1% BSA.

-Migration Assay Procedure
A portion of the experimental BMMC’s were sensitized overnight with 1μg/mL antiDNP IgE in normal Mast Cell Media, while the rest were left untreated. The next day, cells were
washed to remove excess IgE then resuspended at 2e6/mL in Migration Media. 900uL of treated
or control media was placed in the bottom of each appropriate well before inserting the filters
(8um (cat# 3422) Polycarbonate Membrane Transwell Inserts by Corning) that were previously
soaked for 60 minutes in Migration Media. 200μL of cells were carefully added on top of each
filter then allowed to incubate for 4-6 hours. Treatment conditions included 1μg/mL SCF or
negative control (migration media alone).
Cells were collected from the top of the filter and from the wells below in separate FACS
tubes. Resuspended in the same volume (300μL PBS), the unstained cells were run on high
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through BD FACSCanto™ II Analyzer for 60 seconds. Live cells were gated on, then the
number of events from each run was used in the calculation below.
To calculate percent migration:
!"#$%&'$()*+!!"##!!"##"$ − (!"#$%"&!!"##!!"##"$)
!!!100
!"#$%&'$()!"!!"##!!"# + (!"#$%&'$()*+!!"##!!"##"$)
where Experimental wells were those treated with SCF and Control wells with media alone.

Section 5: Mast Cell Enumeration
-Mast Cell Enumeration in Histology
Ear and backskin from three naive WT and KO mice were paraffin-embedded, mounted,
and stained with Pinacyanol Erythrocyanate (PE) by Histo-Scientific Research Laboratories (Mt.

Jackson, VA). 20 individual fields from each tissue sample were counted then averaged for
each mouse. Data graphed based on the separate averages from three tissue replicates.

-Peritoneal Lavage Mast Cell Enumeration
After being sacrificed, mice were injected I.P. with 3mL of 0.1% BSA in cold PBS. The
cavity was agitated for 30 seconds then the liquid was carefully recovered. Resulting cells were
incubated for 5 minutes with Fc blocking reagent 2.4G2 (10μg anti-mouse unlabeled CD16/32)
then stained for 20 minutes with anti-mouse APC-conjugated c-kit (clone 2B8) and anti-mouse
FITC-conjugated FcεRI (clone MAR-1) (Biolegend- San Diego, CA). Cells were examined on a
BD LSRFortessa, data analysis using FCS Express.

Section 6: Beta-Hexosaminidase Release Assay
-Beta-Hex Assay Buffer
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Tyrode’s Salt Solution (cat# T2397 Sigma- St. Louis, MO) was supplemented with
0.04% BSA and 5.6mM glucose.

-Beta-Hex Release Assay Procedure (adapted from published protocol40)
Five million BMMC’s, suspended at 500,000 cells/mL in normal mast cell media, were
sensitized overnight with 1ug/mL anti-DNP IgE. The following day, cells were washed twice
with PBS to remove excess antibody then resuspended at 10e6/mL in Assay Buffer.
100μL of cells (100,000/well) was added to each well in replicates then treated with
100μL of varying concentrations of DNP-BSA (0, 1, 5, 10, 50, 500). After a 30-minute
incubation, the plate was spun to pellet the cells and stop the reaction. 100μL of supernatent was
transferred to a new plate (this will be Percent). After discarding the remaining liquid, 100μL of
5% Triton X-100 was used to lyse the cells then transferred to the new plate (this will be Total).
All new wells were incubated with 50μL of 1mg/mL p-Nitrophenyl N-acetyl-β-Dglucosaminide (PNAG cat#N9376 Sigma- St. Louis, MO) in citrate buffer (40mM citric acid,
20mM sodium phosphate dibasic heptahydrate, pH to 4.5). After two hours, the reaction was
stopped with 100μL of glycine buffer (400mM glycine, pH to 10.7). The plates were read at
405nm.
For each sample and its replicates, there will be two wells: Percent (supernatents alone)
and Total (lysate after adding Triton X). The absorbances from both wells are used in the
calculations below. The calculations must be repeated for each sample.
To calculate Total Mediator Content:
!"#$"%&!×2 + !!"#$%
To calculate percent mediator release:
(!"#$"%&!×!)
!"#$%!!"#$%&'(!!"#$%#$

!
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Section 7: Endothelial Cells
-Aortic Adventitia Digestion Enzyme Solution (AADES)
781.25 units of Collagenase Type II (cat# 17101-015 Life Technologies- Grand Island,
NY) and 14.06 units of Elastase (cat# E7885 Sigma- St. Louis, MO) per 2.5mL PBS

-Aorta Dissociation Enzyme Solution (ADES)
125 units/mL Collagenase Type XI (cat# C7657 Sigma- St. Louis, MO), 60 units/mL
Hyaluronidase Type 1-s (cat# H3506 Sigma- St. Louis, MO), 60 units/mL DNase I , 450
units/mL Collagenase Type I (cat# C0130 Sigma- St. Louis, MO)

-Isolating Aortic Endothelial Cells
The protocol used for enzymatic digestion of the aorta was published by Butcher et al41.
Briefly, aortas underwent double-digestion to first break down the aortic adventitia (using
AADES) then the aorta itself (using ADES). To get enough cells, aortas from four mice were
pooled before being stained with anti-mouse APC-conjugated CD31 (clone 390) (Biolegend- San
Diego, CA) and Histamine Receptors.

Section 8: Passive Systemic Anaphylaxis
-IgE-Mediated PSA
Female mice were sensitized with I.P. injections of 50μg anti-DNP IgE in 200μL saline.
The next day, mice were challenged I.P. with 80ng DNP-BSA (cat# A23018 Life TechnologiesGrand Island, NY) in 200μL saline. Using a murine rectal thermometer, an initial baseline
temperature was taken, followed by time points of 10, 15, or 30 minutes apart as the experiment
progressed. Mice were sacrificed two hours later by cardiac puncture.
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-Histamine-Mediated PSA
Female mice were challenged I.P. with 50μg Histamine Dichloride (cat# H7250 Sigma,
St. Louis, MO) in 200μL saline. Using a murine rectal thermometer, an initial baseline
temperature was taken, followed by time points of 10, 15, or 30 minutes apart as the experiment
progressed. Mice were sacrificed two hours later by cardiac puncture.

Section 9: Nb Infection
Graciously provided by Joe Urban (Agricultural Research Station—Beltsville, MD).
Each experimental mouse was infected sub-cutaneously with approximately 650 stage 3 larvae.
Fecal egg eggs were determined on days 6-9. Serum was collected by tail vein nick on days 7,
14, and 21.

Section 10: Freund’s Adjuvant
-Complete Freund’s Adjuvant
The CFA emulsion was prepared as 1 mg/mL heat-killed M. tuberculosis in mineral oil
combined with 1 mg/mL Ovalbumin in PBS. Each mouse was injected sub-cutaneously with
100uL.

-Incomplete Freund’s Adjuvant
Mice were injected I.P. with a 100μL mineral oil/Ovalbumin boost.

Section 11: Flow Cytometry and Statistical Analysis
-Flow Cytometry
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Single-cell suspensions were incubated with Fc blocking reagent 2.4G2 (10μg unlabeled
anti-mouse CD16/32) then stained on ice for 20 minutes with the appropriate anti-mouse fluoroconjugated antibody. Washed and resuspended in PBS, cells were examined on an LSRFortessa
or Canto (BD Bioscience). Data analysis was performed using FCS Express.

-Statistics
All statistical analysis was performed through GraphPad Prism. Two-group comparisons
were calculated using unpaired two-tailed Student t-Tests, where p-values less than 0.05 were
considered statistically significant. Data error bars represent the mean ± the standard deviation
(SD) between samples.
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-Chapter 3: ResultsKAR KO mice have higher IgE in vivo and in vitro
As reported by Ford et. al42, 129/SvJ mice exhibit hyper-IgE due to mutations in its
suspected negative regulator, CD23. To confirm the same phenomenon exists in the
C57BL/6.129 mixed background, baseline IgE was determined by ELISA. Indeed when
compared their C57BL/6 counterparts, the mixed background mice have higher levels of
baseline IgE (Figure 3-1a). Another result to note is the increased level of baseline of IgE
found in the KAR KO vs. WT, as this will become important later on.

a

b

Cell Density (x103/well)
Figure 3-1. KAR KO mice produce more IgE. B6/129, or “mixed,” background mice have
higher in vivo baseline levels of serum IgE, while C57BL/6 background did not have
detectable levels (a). Supernatents from in vitro stimulation of B6/129 splenic B cells showed
more IgE production by KAR KO B cells (b).
Next, we sought to investigate if stimulated KAR KO B cells produce more IgE in
vitro. Splenic B220+ cells were cultured in IL-4 and anti-CD40 for 9 days, then IgE levels
measured by ELISA. Figure 3-1b shows a representative graph in which KO cells produced
significantly more IgE upon stimulation in vitro. Together, these data show that B6/129 KAR
KO mice have higher IgE levels in vivo as well as increased IgE produced in vitro.
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a

d

Egg Counts
Days 7, 8, 9

Day 7
Bleed

Day 14
Bleed

Day 21
Bleed

Day 0
CFA/
OVA

Day 21
Bleed

Day 42
Bleed

EPG

Day 0
Infect

Day 22
IFA/OVA
boost

b

e

Total IgE (μg/mL)

Figure 3-2. KAR KO exhibit attenuated
TH2 and intact TH1 immune response.
Nb experimental timeline (a). KO had more
eggs per gram feces (b) and produced less
IgE (c) throughout Nb infection.
CFA experimental timeline (d). WT and
KO mice produced comparable levels of
IgG2a during CFA challenge, especially
after IF boost on day 22 (e).

c
KAR KO mice exhibit an attenuated TH2 response
To determine if any TH1/TH2 skewing exists in KAR KO mice, two in vivo models
were employed to test these two opposing immune responses. Once established,
Nippostrongylus brasiliensis (Nb) prompts a robust TH2 response from the host in order to!
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clear the infection. As shown in Figure 3-2b, KAR KO mice had significantly higher fecal
egg counts at the peak of infection at day 7 and until the worms were cleared. Large numbers
of eggs released in feces indicates the host did not effectively control and clear the parasite.
KAR KO mice were also producing less IgE during the infection than the WT (Figure 3-2c).
Althought IgE is not vital for clearing Nb infection, it is an important player in a TH2
response. Together, these results suggest a deficit in the TH2 leg of the KAR KO immune
system.
Although CFA is not a live infection, as the active agent in the emulsion is heat-killed
M. tuberculosis, the model induces a robust TH1 response that can be further amplified by an
IFA boost. Figure 3-2e shows no difference in antigen-specific IgG2a between WT and KAR
KO, indicating they mounted comparable TH1 immune responses.

Allergic Asthma and looking toward mast cells
As discussed in the Introduction, the TH2 branch evolved as a defense mechanism
against multicellular parasite, but is often inappropriately activated by environmental
allergens. The Nb results prompted further investigation into the KAR KO immunophenotype; if the mice mounted a weaker response to Nb, then they should also develop a
weaker sensitivity to allergens.
Mice were sensitized for two weeks, with five days intra-nasal (I.N.) administrations
followed by two days rest then five more days of I.N. After two more days of rest, the
animals were challenged with methacholine, a smooth muscle agonist, to measure Newtonian
Resistance (Rn). This measurement indicates any resistance in the conducting airways, termed
Airway Hyperreactivity (AHR).
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Maximum Resistance (Rn)

Dose of Methacholine (mg/mL)
Figure 3-3. KAR KO mice develop a milder case of allergic asthma.
HDM-sensitized mice were challenged with increasing doses of the agonist Methacholine.
AHR was determined by the maximium resistance measured within the lungs. Red X
indicates animal death during challenge with indicated dose.
Units of Newtonian Resistance (Rn): cmH2O.s/mL
WT mice succumbed to the highest dose of methacholine, as indicated by the red X,
while the KO trailed with significantly lower AHR at each challenge. This experiment
confirmed our hypothesis that KAR KO mice developed a milder case of allergic asthma. In
addition, because AHR is mast cell-dependent, these results directed our attention toward the
mast cell’s role in the KAR KO phenotype.

Characterizing KAR KO mast cells
To determine if there was a difference in the number of tissue-resident mast cells,
samples of ear and backskin were sectioned and stained with Pinacyanol Erythrocyanate (PE).
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As seen in Figure 3-4, there was no difference in distribution (Figure 3-4a, b) or number
(Figure 3-4c) of mast cells within the tissue. Peritoneal lavage, another source for
enumeration, also showed comparable levels of mast cells (Figure 3-3d).

WT

ear

KO

WT

a

backskin

KO

b

c

d

Figure 3-4. KAR KO mice have normal numbers of tissue-resident mast cells.
Representative fields (20X) of mast cell distribution in ear (a) and backskin (b) tissues.
Quantification of tissue-resident mast cells (c). Quantification of mast cells retrieved from
peritoneal lavage (d).

Because it is difficult to obtain large numbers of mast cells from tissue, bone marrowderived mast cells were used for further investigation. To verify the successful differentiation
of both WT and KO BMMCs, analysis by flow cytometry showed equal surface expression of
FcεRI and c-kit (Figure 3-5a, b). Correspondingly, there was no difference in ability to bind
IgE (Figure 3-5c). In order to fully mature in vivo, committed progenitors must leave
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circulation and enter the tissue. Upon exposure to the known mast cell chemotractant SCF,
WT and KAR KO BMMC’s migrated to the same extent in vitro (Figure 3-5d). These data
suggest KAR KO hematopoietic cells differentiate appropriately into committed c-kit+/FcεRI+
mast cells.
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Figure 3-5 KAR KO BMMC’s develop properly in vitro.
Surface expression of c-kit (a) and FcεRI (b) were comparable in WT and KO, indicating
proper maturation of BMMC’s. Both populations bound to IgE equally (c). WT and KAR KO
BMMC’s migrate properly toward SCF (d).

Next was to determine if KAR KO BMMC’s degranulate properly to stimulus.
Lysosomal-Associated Membrane Protein-1 (CD107a) is a heavily glycosylated protein found
on the membrane of internal vesicles such as mast cell or cytotoxic granules as well as
lysosomes. Upon membrane fusion and exocytosis, LAMP-1 can be detected on the cell
surface and thus serves as a marker for degranulation. No difference in ability to degranulate
was found during IgE- nor ionomycin-mediated release (Figure 3-6a).
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a

b

Figure 3-6 KAR KO BMMC’s degranulate appropriately, but release more mediators.
IgE-sensitized KAR KO BMMC’s degranulated to the same extent as WT based on LAMP-1
surface expression (a). The percent release of beta-hexosaminidase, however, was increased
in KO (b).

KAR KO mice exhibit severe anaphylaxis
IgE-mediated PSA is used to evaluate the mast cell’s role in the systemic reaction.
Age-matched female mice were sensitized overnight with anti-DNP IgE then anaphylaxis was
triggered by DNP challenge. Although Figure 3-7a shows an apparent protection of KAR KO
against a severe reaction, this interpretation was deemed invalid. As mentioned in Figure 31a, KAR KO mice have inherently high levels of circulating IgE. We hypothesize that the
mast cells were already coated with non-specific IgE at the time of sensitization. As a result,
less DNP-specific antibody was able to bind the mast cells and prompt degranulation upon
antigen challenge.
In an attempt to circumvent this, an experimental group of mice were treated specially
for three weeks, receiving frequent cage changes in an attempt to reduce exogenous antigens.
We believed the conditions within the animal facility prompted an excess of antibody
production in these mice, especially the knockouts. By the end of this period, the
experimental mice had much lower levels of circulating IgE. KAR KO’s had a three-fold

!

31

reduction to an average of 1.2 ug/mL IgE, while WT levels dropped below 0.03ug/mL. These
experimental mice were then challenged with an IgE-mediated PSA. We chose to cardiac
puncture within five minutes of administering the antigen in order to measure maximum
histamine release within the serum. Figure 3-7c shows that KAR KO mice released
significantly more histamine in vivo upon anaphylaxis.
IgE-Mediated PSA

Histamine-Mediated PSA

a

c

b
Figure 3-7 KAR KO mice release
significantly more histamine in vivo and
overreact to exogenous histamine. Excessive
non-specific IgE in KAR KO circulation
prevented IgE-mediated PSA to occur to a
normal extent (a). Histamine-mediated
degranulation triggered a drastic temperature
drop in KO mice (b). KAR KO released
significantly more histamine upon IgEmediated degranulation following rigorous cage
changes (c).
Histamine-mediated PSA is a way to bypass the mast cell and look at how other

components within the system react. KAR KO mice experienced a drastic temperature drop
and took longer to recover than WT (Figure 3-7b). This indicates that other physiological
components are having exacerbated responses to endogenous or exogenous histamine.
Not only do KAR KO mice release excessive histamine in vivo upon IgE-mediated
degranulation, tissues that respond to histamine also appear to overreact. Many cells
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express histamine receptors (HR), most notably being the endothelial cells. Flow cytometry
analysis showed no difference in HR expression on isolated aortic endothelial cells (Figure 38c) and although there was a slight shift on B cells (Figure 3-8a), splenic B and T cells
(Figure 3-8b) had comparable levels of HR expression.
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-Chapter 4: DiscussionMast cells are important immune cells that are involved in many protective inflammatory
responses; unfortunately they can also contribute to immune diseases. Anaphylaxis is a direct
result of systemic mast cell activation, the severity of which stems from vasoactive histamine.
This and other inflammatory mediators released upon mast cell degranulation also cause the
well-recognized symptoms of allergies—runny nose and sneezing, and asthma—wheezing and
difficulty breathing.
With normal circulating glutamate levels reaching 30-100uM33, many research groups
have begun to study the existence of glutamate receptors outside of the central nervous system
(CNS). This report finds that disrupting the formation of functional kainate receptors (KAR) has
unexpected consequences on immune components, specifically mast cells.
Figure 3-1a showed that mice of the B6/129 mixed background have an elevated IgE
baseline compared to their C57BL/6 counterparts. As discussed in the Introduction, the negative
IgE regulator CD23 is mutated 129/SvJ mice, resulting in excessive IgE in circulation. For KAR
KO’s, this excessive antibody production is further amplified above the WT baseline. This was
also seen in vitro when stimulated KAR KO splenic B cells consistently produced more IgE. It
is unclear if this amplification is seen in other isotypes apart from IgE, though a simple in vitro
experiment could determine this. In addition, future work on this project will transition toward
using KAR KO mice on the C57BL/6 background to resolve the issue of excessive IgE
circulating in 129 strains
Previous work done in our lab showed that glutamate (Glu) and kainic acid (KA)
treatments in vitro increased IgE production by human B cells, a phenomenon that could be
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abrogated by the KAR-specific antagonist, NS102. Data not presented in this report showed
inconsistent responses by purified murine KAR KO B cells to Glu and KA treatments in vitro.
The experiments consistently showed that WT B cells responded to treatments with increased
IgE production. During some of these experiments, the KAR KO B cells acted as predicted:
there was no increase in IgE because they lack the KAR receptor. Many experimental repeats,
however, showed similar increases in IgE production by both the WT and KO B cells. After
much troubleshooting, there still isn’t a firm conclusion about the effects of kainic acid on
murine B cells.
We sought to characterize the KAR KO immune responses, specifically the TH2/TH1
paradigm. When challenged with the parasite Nippostrongylus brasiliensis (Nb), KAR KO mice
produced less IgE while mounting the appropriate response (Figure 3-2c). Although IgE is not
necessary for Nb clearance, this result suggests a deficit in the KAR KO TH2 immune response.
Furthermore, because the mice were unable to mount a complete TH2 response, the worms were
not cleared as effectively as WT. As a result, KAR KO had higher egg counts for the duration of
the infection (Figure 3-2b).
Indeed the results from the allergic asthma model further support this hypothesis. House
Dust Mite (HDM)-sensitized WT mice developed such severe disease, they died upon high doses
of methacholine challenge. KAR KO mice not only survived agonist challenge, they had airway
resistance significantly below WT (Figure 3-3). It is important to note that KAR KO mice still
developed allergic disease, as is evidenced by their saline counterparts. As discussed in the
Introduction, allergies result from an inappropriate TH2 response. This thesis argues that KAR
KO mice have an attenuated TH2 immune response, as seen by 1) reduced ability to clear Nb
infection and 2) the development of an alleviated HDM sensitivity.
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Next we looked toward the other end of the paradigm, the TH1 branch. WT and KAR KO
were injected with heat-killed M. tuberculosis to trigger Toll-Like Receptor (TLR) activation.
The mice mounted equivalent responses to the challenge and boost of Freund’s Adjuvant. In this
case, OVA-specific IgG2a showed no difference between WT and KAR KO TH1 responses
(Figure 3-2e). Combined with the findings discussed above, we concluded that KAR KO mice
have an attenuated TH2 response with an intact TH1 response. This hypothesis had exciting
potential with clear clinical relevance; current allergy treatments are generally immunesuppressive and leave the patient vulnerable to other infections. The phenotype seen in KAR KO
mice suggested a novel protein target that could weaken an overzealous TH2 branch to block
allergies, while preserving the TH1 branch that’s protective against infections such as influenza
and tuberculosis. Reflecting back on these experiments, we were drawn toward the role that
mast cells may be playing.
Beginning in vivo, we found that mast cells in the skin stained appropriately and had
normal distribution and general morphology (Figure3-4). These samples were taken during
naïve conditions, however, and do not speak to the mast cells’ ability to expand during infection.
Gut sections from Nb-infected mice or lung sections from HDM-sensitized mice would give
further insight into how the mast cells function upon challenge.
Because it’s difficult to obtain large amounts of mature mast cells from the animal, bone
marrow-derived mast cells were used for further investigation. Firstly, WT and KAR KO bone
marrow progenitors matured into proper mast cells as indicated by comparable surface
expression of FcεRI and c-kit (Figure 3-5a, b). Subsequent experiments showed several
equalities between WT and KO BMMC’s: 1. ability to bind IgE (Figure 3-5c), 2. migration
toward a chemotractant (Figure 3-4d), and 3. percent degranulation as determined by surface
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LAMP-1 expression (Figure 3-6a). It was concluded that KAR KO mast cells mature, migrate,
and activate appropriately in vivo and in vitro.
Differences arise, however, when quantifying the amount of mediators released from
mast cell granules. Significantly more beta-hex was measured from KAR KO BMMC’s
compared to WT (Figure 3-6b). IgE-mediated PSA also resulted in drastic amounts of histamine
released into circulation of KAR KO mice (Figure 3-7c). These data merit further investigation
into the contents of mast cell granules. Early mediators, such as histamine and TNF-α, and late
mediators, such as IL-13, should be measured from IgE-activated BMMC’s as well as serum
collected early and late during PSA experiments. This information would help to characterize
both the immediate and delayed phases of anaphylaxis.
While both the Nb and CFA models gave basic insight into how KAR KO mice respond
to TH2 vs. TH1 challenges, there are many more components to these immune responses that were
not examined. Indeed, neither IgE nor mast cells are absolutely necessary for the clearance of
Nb infections, yet there was a clear deficiency in the KAR KO’s response as indicated by the
higher fecal egg counts. These experiments must be repeated to look at cytokine expression and
involvement of other immune cells in order to make firm conclusions about these immune
branches.
The results from the allergic asthma model are also intriguing and there is much more
data to collect from this type of experiment. Shannon Li et. al43 published a three-week HDMsensitization protocol that induces much more mast cell expansion within the lungs. This model
better mimics the pathology seen in human allergic asthma. As discussed in the Introduction,
chronic disease marked by prolonged inflammation causes irreversible lung and airway damage.
Methacholine challenge is used to evaluate bronchoconstriction due to this airway remodeling,
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and thus is an assessment of the late phase reaction. Challenging with HDM extract, on the other
hand, can be used to assess the early phase reaction by measuring tissue dampening (G) and lung
elastance (H), which are indicative of acute phase bronchospasms. This line of experiments
would allow a thorough examination of the disease state and how KAR KO differ from WT.
Because the issue of elevated non-specific IgE was not realized until late, all IgEmediated anaphylaxis must be repeated in order to collect true temperature drops based on full
mast cell degranulation. The experimental mice that received frequent cage changes showed
surprising amounts of histamine released upon IgE-mediated PSA, but because cardiac puncture
was performed within five minutes, no temperature readings were acquired from these mice.
It is surprising that in addition to excessive histamine being released in vivo, KAR KO
mice also show an exaggerate response to exogenous histamine treatments. The detection of
histamine receptors on endothelial cells needs to be repeated, as it was only performed once due
to the necessity of pooling four mice. We expected to find higher expression of histamine
receptors (HR) in KAR KO mice to explain the exaggerated response, but there was no
difference found on aortic endothelial cells. A Mile’s Assay will be performed to quantify
vascular leakage resulting from histamine-mediated passive cutaneous anaphylaxis (PCA).
In summary, this report presents preliminary findings from the immuno-characterization
of KAR KO mice. Many experiments discussed will be expanded in the future to acquire more
in-depth data; this includes cytokine production in vivo and in vitro, histology from Nb and
asthma models, additional mediator release assays, as well as the continued investigation into
histamine receptors. Although there initially appeared to be clinical potential for a kainate
receptor antagonist to attenuate allergies, the adverse response to histamine may limit this
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prospect. Overall, the unique KAR KO phenotype is interesting and could provide new insight
into the balance between different branches of the immune system.
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